Clinical Trials Logo

Giardia Lamblia Infection clinical trials

View clinical trials related to Giardia Lamblia Infection.

Filter by:
  • None
  • Page 1

NCT ID: NCT04827537 Active, not recruiting - Clinical trials for Giardia Lamblia Infection

Anti-protozoal Effect of Steroid Hormone 20-hydroxyecdysone

Start date: January 1, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

20-hydroxyecdysone is an ecdysteroid hormone found in invertebrates and plants. 20-hydroxyecdysone exhibits a broad range of biological properties in various in vitro and in vivo models, including anabolic, antioxidant, anti-inflammatory, immunomodulatory, anti-obesity and antidiabetic activities, in addition to acting as neuroprotective and hepatoprotective agent. Ecdysteroids are widely used by athletes as dietary supplements to increase strength and muscle mass during resistance training, to reduce fatigue and to ease recovery. Mhashilkar AS et al. (2016) were revealed anti-parasitic activity of 20-hydroxyecdysone against the human filarial parasites. According to recent searches in academic databases and medical search engines (Google, www.google.com; PubMed, www.ncbi.nlm.nih.gov/pubmed; and Medline, www.medline.com), no studies have been conducted to assess the anti-protozoal activity of 20-hydroxyecdysone. The aim of the study is to assess anti-protozoal activity of 20-hydroxyecdysone in water sports athletes with giardiasis.

NCT ID: NCT04778280 Recruiting - Clinical trials for Giardia Lamblia Infection

Vitamin D Estimation With Giardia Lamblia Infections

Start date: February 17, 2021
Phase:
Study type: Observational

investigators will take stool and blood samples from two groups of humans :- 1-group A (healthy group negative Giardia or control group),2-group B (positive Giardia or case group)then investigators make estimation for vitamin D in both groups then investigators try to find if there is relation between vitamin D level and Giardia lamblia infections